May be a dumb question, but why would you set yourself up to pay $4.20/shr in Dec when you can buy the stock right now for only $3? There's really nothing that's going to make this pop again with the possible exception of the CANTOS trial results, but they're coming out in a couple weeks, and we already saw the first CANTOS AMRN pop occur, didn't last much more than a month.